QUCY Short Volume
Mainz Biomed N.V. (QUCY) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $36.7M, listed on NASDAQ, employing roughly 26 people, carrying a beta of 0.43 to the broader market. Mainz Biomed NV is a molecular genetics cancer diagnostic company. Led by Guido Baechler, public since 2021-11-05.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 1.1M
- Total Volume
- 2.2M
- Short %
- 50.44%
- 30-Day Avg Short %
- 50.97%
Showing 30 days of FINRA short volume data for Mainz Biomed N.V..
Learn how short volume is reported and how to read the data →
Frequently asked QUCY short volume questions
- What is the daily QUCY short volume?
- As of Jun 1, 2026, Mainz Biomed N.V. (QUCY) short volume is 1.1M shares against 2.2M total reported volume, or 50.44% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is QUCY short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does QUCY short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.